News
-
Safran information
-
Information Safran
-
Rapport semestriel SIEHM au 30 avril 2026
-
Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
-
Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
-
Vox Royalty Sells I-80 Gold Offtake Stream
-
SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
-
Dateline Chairman Invests $1.95 million through Options Exercise
-
Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
-
Northern Dynasty Reports Oral Arguments Held
-
Hong Kong celebrates surge of global enterprises driving investment and opportunities
-
Bitcoin Group SE publishes 2025 Annual Report: Strategic realignment ensures future viability in the dynamic crypto market
-
Porsche ranks number one in J.D. Power 2026 U.S. Initial Quality Study
-
Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share
-
AlphaESS Unveils Expanded Energy Storage Ecosystem for Europe at Intersolar 2026